3,3', 4,4'-TETRAHYDROXY-2,2' -BIPYRIDINE-N,N' -DIOXIDES FOR THE TREATMENT OF RENAL CELL CARCINOMA

摘要

Methods are provided of treating renal cancer by administration of certain 3,3',4,4'- tetrahydroxy-2,2'-bipyridine-N,N'-dioxide compounds, especially 3,3',4,4'-tetrahydroxy-2,2'-bipyridine-N,N'-dioxide (Orellanine), using particular administration protocols and dosing regimens, as well as pharmaceutical compositions suitable for use in the treatment methods that are provided.